Personalizing Decisions PSA screenings for Men
Channel: BioBalance Healthcast
Date: 2018-06-23

Read more at https://www.biobalancehealth.com

There are new standards regarding PSA screenings for men as they age. Men have been told for decades that if they live long enough they will all die from prostate cancer. After age 40 men were told that they should get a psa test once a year and that they should also receive a digital exam by their physician. Today those requirements are no longer standard. 

“The United States Preventive Services Task Force (USPSTF) on May 8,2018 released a report with new recommendations regarding both PSA tests and digital screenings. It said that for men ages 55-69, the decision to undergo periodic PSA based screening for prostate cancer should be individualized…. A “C” recommendation. “Individuals and physicians should consider the balance of benefits and harms on the basis of family history, race/ethnicity, comorbid medical conditions, patient values about the benefits and harms of screening and treatment-specific outcomes, and other health needs. Physicians should not screen men who do not express a preference for screening.

For men age 70 and older the potential benefits of PSA based screening don’t outweigh the harms, so this group should not be screened for prostate cancer… a “D” recommendation.


Click here to read the full publication
https://www.biobalancehealth.com/wp-content/uploads/2018/05/PSA-Screening-for-Men-Ages-55-69.pdf


Adequate evidence from randomized clinical trials also showed no prostate cancer mortality benefit of PSA based screening for men age 70 and older.”

It is now believed that there can be direct harm from poor diagnostic procedures. These include complications from the biopsy as at least 1% of biopsies result in complications requiring hospitalization. 

The report also concluded that we should not screen men over age 70 because they do not report a mortality benefit for men over 70, but they do show increased likelihood of harm from screening, diagnostic evaluation, treatment, over-diagnosis and over treatment. These harms can be psychological, and they can also occur as a result of active surveillance. Therefore, go gently or do not go at all when thinking about PSA screening for men over the age of 70.